Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net loss - before noncontrolling interest (“NCI”)	$ (103,238)	$ (56,126)
Adjustments to reconcile net loss - before NCI to net cash used in operating activities
Depreciation and amortization expense	2,457	226
Stock-based compensation	19,532	15,009
In-process R&D charge		133
APA-RDx: Issue common stock of majority-owned subsidiary - settle installment payment	653
Change in fair value - Senior Secured Convertible Note	1,273	(1,682)
Loss upon Issuance - Senior Secured Convertible Note	3,523
Debt extinguishment loss - Senior Secured Convertible Notes and Senior Convertible Note	5,434	3,715
Debt forgiveness		(300)
Non-cash lease expense	97
Changes in operating assets and liabilities:
Accounts receivable	183	(200)
Prepaid expenses, deposits and current and other assets	397	(3,458)
Accounts payable	(742)	174
Accrued expenses and other current liabilities	(554)	1,918
Net cash flows used in operating activities	(70,985)	(40,591)
Cash flows from investing activities
Purchase of equipment	(1,540)	(1,469)
Asset acquisitions, net of cash	(3,200)	(2,247)
Net cash flows used in investing activities	(4,740)	(3,716)
Cash flows from financing activities
Proceeds – issue of common stock - initial public offering - majority-owned subsidiary		62,000
Payment – offering costs - initial public offering - majority-owned subsidiary common stock		(5,665)
Proceeds – issue of common stock – registered offerings		55,016
Payment – offering costs – registered offerings		(1,312)
Proceeds – issue of Senior Secured Convertible Note, net of offering costs	35,227
Payment – repayment of Senior Convertible Note and Senior Secured Convertible Note		(14,816)
Payment – Senior Convertible Note and Senior Secured Convertible Note – non-installment payments		(154)
Proceeds – issue of common stock - At-The-Market Facility	79
Proceeds – majority-owned subsidiary common stock - Committed Equity Facility	1,807
Proceeds – exercise of Series Z warrants		7,804
Proceeds – exercise of Series W warrants		20
Proceeds – exercise of stock options	302	980
Proceeds – issue common stock – Employee Stock Purchase Plan	358	436
Proceeds – majority-owned subsidiary common stock – Employee Stock Purchase Plan	109
Proceeds – exercise of stock options issued under equity plan of majority owned subsidiary	695
Purchase Treasury Stock – payment of employee payroll tax obligation in connection with stock-based compensation	(366)
Net cash flows provided by financing activities	38,211	104,309
Net increase (decrease) in cash	(37,514)	60,002
Cash, beginning of period	77,258	17,256
Cash, end of period	$ 39,744	$ 77,258